GPX1 and type 2 diabetes mellitus: At the same time, A10-FMT increased systemic antioxidant capability through the total antioxidant capability (T-AOC) of the blood and GPX1 in liver (Fig. 4h to j); however, the data were not significant between Con and HS (Fig. 4h to j), which suggests that the changes observed may not be representative for T2D.